Literature DB >> 16007343

Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production.

Kirk H M Yip1, Ming H Zheng, James H Steer, Tindaro M Giardina, Renzhi Han, Susan Z Lo, Anthony J Bakker, A Ian Cassady, David A Joyce, Jiake Xu.   

Abstract

UNLABELLED: The mechanism by which TG modulates osteoclast formation and apoptosis is not clear. In this study, we showed a biphasic effect of TG on osteoclast formation and apoptosis through the regulation of ROS production, caspase-3 activity, cytosolic Ca2+, and RANKL-induced activation of NF-kappaB and AP-1 activities.
INTRODUCTION: Apoptosis and differentiation are among the consequences of changes in intracellular Ca2+ levels. In this study, we investigated the effects of the endoplasmic reticular Ca2+-ATPase inhibitor, thapsigargin (TG), on osteoclast apoptosis and differentiation.
MATERIALS AND METHODS: Both RAW264.7 cells and primary spleen cells were used to examine the effect of TG on RANKL-induced osteoclastogenesis. To determine the action of TG on signaling pathways, we used reporter gene assays for NF-kappaB and activator protein-1 (AP-1) activity, Western blotting for phospho-extracellular signal-related kinase (ERK), and fluorescent probes to measure changes in levels of intracellular calcium and reactive oxygen species (ROS). To assess rates of apoptosis, we measured changes in annexin staining, caspase-3 activity, and chromatin and F-actin microfilament structure.
RESULTS: At concentrations that caused a rapid rise in intracellular Ca2+, TG increased caspase-3 activity and promoted apoptosis in osteoclast-like cells (OLCs). Low concentrations of TG, which were insufficient to measurably alter intracellular Ca2+, unexpectedly suppressed caspase-3 activity and enhanced RANKL-induced osteoclastogenesis. At these lower concentrations, TG potentiated ROS production and RANKL-induced NF-kappaB activity, but suppressed RANKL-induced AP-1 activity and had little effect on ERK phosphorylation.
CONCLUSION: Our novel findings of a biphasic effect of TG are incompletely explained by our current understanding of TG action, but raise the possibility that low intensity or local changes in subcellular Ca2+ levels may regulate intracellular differentiation signaling. The extent of cross-talk between Ca2+ and RANKL-mediated intracellular signaling pathways might be important in determining whether cells undergo apoptosis or differentiate into OLCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007343     DOI: 10.1359/JBMR.050324

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  27 in total

1.  p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.

Authors:  Kirk H M Yip; Haotian Feng; Nathan J Pavlos; Ming H Zheng; Jiake Xu
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

2.  Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss.

Authors:  Julia Barsony; Yoshihisa Sugimura; Joseph G Verbalis
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

3.  Enhanced osteoclastogenesis by mitochondrial retrograde signaling through transcriptional activation of the cathepsin K gene.

Authors:  Manti Guha; Satish Srinivasan; Alexander Koenigstein; Mone Zaidi; Narayan G Avadhani
Journal:  Ann N Y Acad Sci       Date:  2015-03-18       Impact factor: 5.691

4.  Osteoclast precursor differentiation by MCPIP via oxidative stress, endoplasmic reticulum stress, and autophagy.

Authors:  Kangkai Wang; Jianli Niu; Hyunbae Kim; Pappachan E Kolattukudy
Journal:  J Mol Cell Biol       Date:  2011-10-11       Impact factor: 6.216

5.  Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.

Authors:  HaoTian Feng; Taksum Cheng; James H Steer; David A Joyce; Nathan J Pavlos; Chengloon Leong; Jasreen Kular; Jianzhong Liu; Xu Feng; Ming H Zheng; Jiake Xu
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

6.  NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-κB.

Authors:  Hengwei Zhang; Matthew J Hilton; Jennifer H Anolik; Stephen L Welle; Chen Zhao; Zhenqiang Yao; Xing Li; Zhiyu Wang; Brendan F Boyce; Lianping Xing
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

7.  Thapsigargin induces apoptosis of prostate cancer through cofilin-1 and paxillin.

Authors:  Fengyu Huang; Peitao Wang; Xinsheng Wang
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

8.  Hypoxia-mediated mitochondrial stress in RAW264.7 cells induces osteoclast-like TRAP-positive cells.

Authors:  Satish Srinivasan; Narayan G Avadhani
Journal:  Ann N Y Acad Sci       Date:  2007-11       Impact factor: 5.691

9.  Water-soluble fullerene (C60) inhibits the osteoclast differentiation and bone destruction in arthritis.

Authors:  Kazuo Yudoh; Rie Karasawa; Kayo Masuko; Tomohiro Kato
Journal:  Int J Nanomedicine       Date:  2009-10-19

10.  Water-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis.

Authors:  Kazuo Yudoh; Rie Karasawa; Kayo Masuko; Tomohiro Kato
Journal:  Int J Nanomedicine       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.